China Meheco Group Co

China Meheco Group Co FCF Yield

The Free Cash Flow Yield of China Meheco Group Co (600056.SS) as of Oct 19, 2026 is 6.92 %. In the previous year, Free Cash Flow Yield was 4.10 % — a change of 68.95% (higher).

FCF Yield

6.92 %

YoY

68.95%

Last updated:

Free Cash Flow Yield of China Meheco Group Co is 2025 6.92 % . Free Cash Flow Yield of China Meheco Group Co was 2024 4.10 % . It decreases by 68.95% higher compared to the previous year.

The China Meheco Group Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-1.66 CNY
Jan 1, 2019
-2.12 CNY
Jan 1, 2020
7.87 CNY
Jan 1, 2021
-0.87 CNY
Jan 1, 2022
8.98 CNY
Jan 1, 2023
3.15 CNY
Jan 1, 2024
4.10 CNY
Jan 1, 2025
6.92 CNY
The China Meheco Group Co FCF Yield history
YEARFCF YieldYoY
6.92 %+68.95%
4.10 %+30.27%
3.15 %-64.96%
8.98 %-1,128.79%
-0.87 %-111.09%
7.87 %-471.55%
-2.12 %+27.71%
-1.66 %-165.33%
2.54 %-52.90%
5.39 %-4.90%
5.67 %-0.42%
5.69 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

China Meheco Group Co Stock analysis

What does China Meheco Group Co do? China Meheco Group Co Ltd is a healthcare company based in Beijing, China, operating within the healthcare sector. The company has been publicly traded since May 15, 1997, with its stock listed under the ticker 600056.SS and ISIN CNE000000Q29. It employs 8,313 full-time staff. China Meheco Group engages in the wholesale distribution of medicines, drugs, and Chinese herbal medicine. The company's operations are structured into three main segments: Industrial Pharmaceutical, Commercial Pharmaceutical, and Trading. The Industrial Pharmaceutical segment focuses on the manufacturing and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment handles the wholesale and distribution of pharmaceuticals and medical devices. The Trading segment is involved in international exporting and the introduction of medical resources. The company maintains a website at http://www.meheco.com for further information. China Meheco Group operates within the healthcare industry, contributing to the pharmaceutical supply chain in China and beyond through its diversified business segments. China Meheco Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about China Meheco Group Co stock

Free Cash Flow Yield of China Meheco Group Co is 6.92 % in 2025.

Free Cash Flow Yield of China Meheco Group Co changed from 4.10 % to 6.92 %, representing a 68.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield China Meheco Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's China Meheco Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — China Meheco Group Co

All Key Metrics — China Meheco Group Co